二尖瓣手术同期外科消融房颤改善远期生存:波兰国家心脏手术登记分析
基于波兰国家心脏手术登记(KROK)2006至2017年37个中心11,381例基线房颤行二尖瓣手术患者的回顾性分析,其中2449例(21.5%)同期接受外科消融。
要点
- 二尖瓣手术同期外科消融房颤与远期生存改善独立相关。
- 低危患者(EuroSCORE 2-5或年龄<50岁)获益最明显。
核心结论
- 二尖瓣手术同期行外科消融治疗房颤安全、可行,并显著改善远期生存。
研究设计与样本
- 回顾性分析波兰国家心脏手术登记(KROK)2006至2017年37个参考中心的数据。
- 共纳入11,381例基线房颤接受二尖瓣手术的患者,其中2449例(21.5%)同期行外科消融。
- 中位随访5年(均值4.6年,四分位距1.9-7.9年),采用Cox比例风险模型及倾向性评分匹配(1784对)比较二尖瓣手术+消融与单纯二尖瓣手术。
主要发现
- 亚组分析中获益持续存在,但低危患者(如EuroSCORE 2-5或年龄<50岁)获益最明显。
临床怎么用
- 对于接受二尖瓣手术的基线房颤患者,可考虑同期行外科消融以改善远期生存。
- 低危患者(EuroSCORE 2-5或年龄<50岁)可能从同期消融中获益更显著。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Surgical ablation for atrial fibrillation (AF) performed at the time of other valvular- or nonvalvular cardiac procedure is a mainstay of therapy; yet the data regarding its influence on remote survival are sparse. We aimed to evaluate late survival in patients undergoing mitral valve (MV) surgery with concomitant surgical ablation for AF. METHODS: Procedure-related data from the Polish National Registry of Cardiac Surgery Procedures (Krajowy Rejestr Operacji Kardiochirurgicznych) were retrospectively collected. A total of 11,381 patients with baseline AF (46.6% men; mean age 65.6 ± 9.0 years) undergoing MV surgery between 2006 and 2017 in 37 reference centers across Poland and included in the registry were analyzed. Median follow-up was 5 years (mean, 4.6 years; interquartile range, 1.9-7.9 years). Cox proportional hazards models were used for computations. Propensity score matching for the comparison of MV + ablation versus MV alone was performed. RESULTS: Of included patients, 2449 (21.5%) underwent surgical ablation for AF. Patients in this group were significantly younger (63.8 ± 8.7 years vs 66.1 ± 9.0 years; P < .001) and were at lower baseline surgical risk (EuroSCORE, 2.86 vs 3.69; P < .001). During the 12-year study period, there was a significant survival benefit (hazard ratio, 0.71; 95% confidence interval, 0.63-0.79; P < .001) for MV + ablation compared with MV alone. After rigorous propensity matching (logit model, 1784 pairs) surgical ablation was associated with nearly 20% improved survival (hazard ratio, 0.82; 95% confidence interval, 0.70-0.96; P = .011). Benefit of surgical ablation was maintained in subgroup analyses, yet most benefit was appraised in low-risk patients such as those with EuroSCORE of 2 to 5 or age < 50 years. CONCLUSIONS: Concomitant surgical ablation for AF in patients undergoing mitral valve procedures is safe, feasible, and significantly improves late survival.
引用
- Suwalski P, Kowalewski M, Jasiński M, et al. Survival after surgical ablation for atrial fibrillation in mitral valve surgery: Analysis from the Polish National Registry of Cardiac Surgery Procedures (KROK). J Thorac Cardiovasc Surg. 2018. PMID: 30314688. doi:10.1016/j.jtcvs.2018.07.099
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。